During the past decade, Herzzentrum der Universität zu Köln conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 5 clinical trials were completed, i.e. on average, 21.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herzzentrum der Universität zu Köln" #1 sponsor was "Edwards Lifesciences" with 4 trials, followed by "CVRx, Inc." with 3 trials sponsored, "Symetis SA" with 3 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored and "Acutus Medical" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herzzentrum der Universität zu Köln" #1 collaborator was "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 3 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 3 trials as a collaborator, "Abbott Medical Devices" with 2 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator and "Charite University, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Herzzentrum der Universität zu Köln" are "Heart Failure" (5 trials), "Aortic Valve Stenosis" (4 trials), "Aortic Stenosis" (2 trials), "Cardiovascular Diseases" (2 trials) and "Heart Valve Diseases" (2 trials). Many other conditions were trialed in "Herzzentrum der Universität zu Köln" in a lesser frequency.

Most popular intervention types in "Herzzentrum der Universität zu Köln" are "Device" (22 trials), "Procedure" (5 trials), "Drug" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "BAROSTIM NEO™ System" (2 trials), "JenaValve Pericardial TAVR System" (2 trials), "ABSORB Scaffold" (1 trials), "ACURATE TA™ Transapical Aortic Bioprosthesis" (1 trials) and "ACURATE TF™" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum der Universität zu Köln" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Herzzentrum der Universität zu Köln". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Herzzentrum der Universität zu Köln, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum der Universität zu Köln, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 15 trials that are defined as “Not Applicable".